← Eichor
Study identifier: NCT06962397 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effectiveness of Active Exploration of Simulated Textures for Sensorimotor Recovery

Condition: Stroke · Sensorimotor Impairment Affecting the Upper Limb · Sensory Deficit  ·  Sponsor: Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Parallel-group, single-blinded controlled clinical trial. The study includes people aged 18-80 years, more than one month after stroke, with confirmed diagnosis, MoCA ≥ 20, and Barthel Index ≥ 3. The control group receives standard rehabilitation. The experimental group also receives active sensory training with programmable electrical stimulation to simulate virtual textures. Sensory function was assessed before and after the training using standard tests, including Fugl-Meyer, ARAT, 9HPT, and monofilament testing.

This description comes directly from the study's public registry record.

Talk to the study team

Maria Volodina, PhD in Physiology  ·  +79162528715  ·  mariavolodina@yandex.ru

Always discuss trial participation with your own doctor first.

Locations (1)

Federal Center of Cerebrovascular Pathology and StrokeMoscow, RussiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06962397